Zytronic PLC
01 October 2007
ZYTRONIC PLC
Director's Share Dealing
Zytronic plc (the 'Company') announces that it has received notification that,
on Friday 28 September, Mark Cambridge, Director:
1) exercised options under an unapproved share option scheme over 21,818
Ordinary Shares in the Company at an exercise price of 110p per share;
and
2) purchased 10,000 Ordinary Shares in the Company at a price of 172p per
share.
Following the above purchase, Mr Cambridge has an interest in 36,113 Ordinary
Shares in the Company, representing approximately 0.2463% of the Total Voting
Rights.
For further information:
Denis Mullan, Zytronic plc 0191 414 5511
Alan Stewart, Brewin Dolphin (NOMAD) 0845 213 1120
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.